Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma
2019
321 citations
Journal Article
Field-Weighted Citation Impact:
17.99
Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma | Researchclopedia
·
Sheba Medical Center
Paola Queirolo
·
Ospedale Policlinico San Martino
Georgina V. Long
·
Royal North Shore Hospital
Anna Maria Di Giacomo
·
University of Siena
Inge Marie Svane
·
University of Copenhagen
Michal Lotem
·
Hadassah Medical Center
Gil Bar‐Sela
·
Rambam Health Care Campus
Félix Couture
·
Centre hospitalier universitaire de Québec
Bijoyesh Mookerjee
·
Novartis (United States)
Razi Ghori
·
Merck & Co., Inc., Rahway, NJ, USA (United States)
Nageatte Ibrahim
·
Merck & Co., Inc., Rahway, NJ, USA (United States)
Blanca Homet Moreno
·
Merck & Co., Inc., Rahway, NJ, USA (United States)
Antoni Ribas
·
University of California, Los Angeles